-
September 18, 2012
GlaxoSmithKline (GSK) recently announced it has hiked its stake in Response Genetics Inc. (RGDX), a company focused ...
-
September 18, 2012
We recently reiterated our Neutral recommendation on Auxilium Pharmaceuticals, Inc. (AUXL) which carries a Zacks #3 ...
-
September 18, 2012
In an attempt to develop its diagnostics business, Life Technologies (LIFE) entered into a Master Development ...
-
September 14, 2012
Biogen Idec (BIIB) recently announced that it has sold its royalty and other rights related to GlaxoSmithKline's ...
-
September 14, 2012
New York, September 14th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) closed the session at ...
-
September 13, 2012
Abbott Laboratories (ABT) recently announced that it is collaborating with Astellas Pharma Global Development for a ...
-
September 12, 2012
Dr. Reddy's Laboratories (RDY) recently announced the launch of its generic version of AstraZeneca's (AZN) ...
-
September 06, 2012
New York, September 6th (TradersHuddle.com) - Shares of GlaxoSmithKline plc (NYSE:GSK) are trading
very close to ...
-
August 29, 2012
Par Pharmaceuticals Companies Inc. (PRX) recently announced that the "go shop" period under the terms of the earlier ...
-
August 27, 2012
Roche Holdings Ltd. (RHHBY) recently announced results from its phase III study (EMILIA study) of trastuzumab ...
-
August 27, 2012
GlaxoSmithKline (GSK) and Theravance, Inc. (THRX) recently announced that they have completed the phase III program ...
-
August 24, 2012
GlaxoSmithKline (GSK) and Janssen Biologics' (Ireland) human anti-interleukin (IL)-6 monoclonal antibody, sirukumab ...
-
August 23, 2012
New York, August 23rd (TradersHuddle.com) - GlaxoSmithKline plc (NYSE:GSK) closed the trading day at $45.86, near ...
-
August 22, 2012
Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals (ALNY) and Isis Pharmaceuticals, Inc. (ISIS), recently ...
-
August 21, 2012
Mylan Inc. (MYL) recently announced that its UK and Italian subsidiaries have launched its generic version of ...
-
August 16, 2012
Regulus Therapeutics Inc. and Biogen Idec (BIIB) recently entered into a deal to identify microRNAs ...
-
August 16, 2012
GlaxoSmithKline plc (GSK) recently announced that it has entered into an agreement with Aspen Global Incorporated, a ...
-
August 14, 2012
GlaxoSmithKline, plc's (GSK) second quarter earnings of $0.79 per ADS were below the Zacks Consensus Estimate of ...
-
August 13, 2012
Perrigo Company (PRGO) recently received some good news when the US Food and Drug Administration (FDA) cleared its ...
-
August 10, 2012
Vivus Inc.'s (VVUS) second quarter 2012 loss of 24 cents per share was wider than the Zacks Consensus loss Estimate ...
